Narcolepsy News and Research

RSS
Narcolepsy is a chronic sleep disorder, or dyssomnia. The condition is characterized by excessive daytime sleepiness (EDS) in which a person experiences extreme fatigue and possibly falls asleep at inappropriate times, such as while at work or at school.
Scientists develop potent compound that promotes wakefulness, remedies sleep disorder narcolepsy

Scientists develop potent compound that promotes wakefulness, remedies sleep disorder narcolepsy

Study: Children with TBI more likely to experience daytime sleepiness, sleep disturbances

Study: Children with TBI more likely to experience daytime sleepiness, sleep disturbances

Jazz enrolls first patients in JZP-110 Phase 3 study for treatment of EDS in patients with narcolepsy or OSA

Jazz enrolls first patients in JZP-110 Phase 3 study for treatment of EDS in patients with narcolepsy or OSA

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

AASM publishes new quality measures for common sleep disorders

AASM publishes new quality measures for common sleep disorders

Narcolepsy bears trademarks of classic autoimmune disorder

Narcolepsy bears trademarks of classic autoimmune disorder

Adolescents experience excessive daytime sleepiness due to marijuana use

Adolescents experience excessive daytime sleepiness due to marijuana use

Merck announces US availability of BELSOMRA (suvorexant) for treatment of insomnia

Merck announces US availability of BELSOMRA (suvorexant) for treatment of insomnia

Protein that awakens brain from sleep may fight against Alzheimer's disease

Protein that awakens brain from sleep may fight against Alzheimer's disease

MGH investigators develop system to accurately track the process of falling asleep

MGH investigators develop system to accurately track the process of falling asleep

FDA approves BELSOMRA® (suvorexant) for the treatment of insomnia

FDA approves BELSOMRA® (suvorexant) for the treatment of insomnia

Proteins causing daytime sleepiness also play crucial role in bone formation

Proteins causing daytime sleepiness also play crucial role in bone formation

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Smart drugs have lasting side-effects on young people's brain

Smart drugs have lasting side-effects on young people's brain

Form of baclofen works better at treating narcolepsy

Form of baclofen works better at treating narcolepsy

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.